Of the first four experimental ALS treatments tested in the HEALEY platform trial, CNM-Au8 and pridopridine showed some ...
The company will discontinue development of its original ALS gene therapy candidate VY9323 amid toxic effects in nonhuman ...
Having access to neurofilament light chain and the ALS Functional Rating Scale-Revised test results is informational to ALS ...
After a stretch of dire respiratory illness, columnist Kristin Neva and her husband, who has ALS, are feeling renewed energy and optimism.
In a statement, the ALS Association opposed any planned National Institutes of Health (NIH) funding cuts, saying it could undermine research.